FEBS J. 2024 Oct;291(20):4633. doi: 10.1111/febs.17268. Epub 2024 Sep 30.
H. Li, R. Yan, W. Chen, X. Ding, J. Liu, G. Chen, Q. Zhao, Y. Tang, S. Lv, S. Liu, and Y. Yu, "Long Non Coding RNA SLC26A4-AS1 Exerts Antiangiogenic Effects in Human Glioma by Upregulating NPTX1 Via NFKB1 Transcriptional Factor," The FEBS Journal 288, no. 1 (2021): 212-228, https://doi.org/10.1111/febs.15325. The above article, published online on July 15, 2020, in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief; the Federation of European Biochemical Societies; and John Wiley & Sons Ltd. The retraction has been agreed upon following an investigation into concerns raised by a third party, which revealed inappropriate image duplication between this article (Fig. 1E) and another article previously published elsewhere by a different group of authors in a different scientific context. The authors were unable to provide a satisfactory explanation, and the partial raw data they supplied could not explain the identified issues. Consequently, the editors have lost confidence in the presented data and decided to retract the paper.
H. 李、R. 严、W. 陈、X. 丁、J. 刘、G. 陈、Q. 赵、Y. 唐、S. 吕、S. 刘和Y. 于，“长链非编码RNA SLC26A4-AS1通过NFKB1转录因子上调NPTX1在人胶质瘤中发挥抗血管生成作用”，《欧洲生物化学学会联合会会刊》288卷，第1期（2021年）：212 - 228页，https://doi.org/10.1111/febs.15325 。上述文章于2020年7月15日在线发表于威利在线图书馆（wileyonlinelibrary.com），已由期刊主编、欧洲生物化学学会联合会和约翰·威利父子有限公司协商一致撤回。此次撤回是在对第三方提出的担忧进行调查后达成的，调查发现本文（图1E）与另一组不同作者在不同科学背景下先前在其他地方发表的另一篇文章之间存在不适当的图像重复。作者无法提供令人满意的解释，并且他们提供的部分原始数据也无法解释所发现的问题。因此，编辑们对所呈现的数据失去了信心，决定撤回该论文。
